After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Verona Pharma Plc ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Verona Pharma Plc ADR is $9.10B. A total of 0.78 million shares were traded on the day, compared to an average of 3.48M shares.
In the most recent transaction, Cunningham Kenneth sold 10,808 shares of VRNA for 13.14 per share on Aug 01 ’25. After the transaction, the Director now owns 79,776 company shares. In a previous transaction on Aug 01 ’25, Deschamps Lisa sold 9,464 shares at 13.14 per share. VRNA shares that Director owns now total 84,856.
Among the insiders who sold shares, Fisher Andrew disposed of 9,584 shares on Aug 01 ’25 at a per-share price of $13.14. This resulted in the General Counsel holding 417,903 shares of VRNA after the transaction. In another insider transaction, Hahn Mark W sold 208,912 shares at $13.14 per share on Aug 01 ’25. Company shares held by the Chief Financial Officer now total 12,464,968.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, VRNA has a high of $105.85 and a low of $24.50.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $3.24, while its Total Shareholder’s Equity was $148.00M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRNA is Buy with a score of 3.17.
